-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2021 to Q1 2025.
- NewAmsterdam Pharma Co N.V. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2025 was $2.86M.
- NewAmsterdam Pharma Co N.V. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$62.8M, a 261767% decline from 2023.
- NewAmsterdam Pharma Co N.V. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$24K, a 89.1% increase from 2022.
- NewAmsterdam Pharma Co N.V. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$221K, a 821% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)